Reading time: 5 minutes Anthony Tao Introduction For cancer to successfully grow, one of the major obstacles it must face is the immune system. Cells of the immune system, such as T cells, have natural and effective mechanisms that allow them to monitor the body and attack any cancer cell that might arise. For decades,... Continue Reading →
Reading time: 4 minutes Anthony Tao Sunny weather can make the difference between a bleak and mundane work day versus a day filled with joy and festivity. People generally feel better when the sun's out. Foods taste better, music sounds livelier, and the air feels more hopeful. And the need for hope is perhaps most... Continue Reading →
Reading time: 4 minutes Colette Bilynsky The wonders of cellular therapies and immunotherapies have been often discussed here on Oncobites. But one of the challenges here is that these strategies are dependent on immune cells' ability to reach tumors and still function. However, tumors will often try to evade and stop the immune system from... Continue Reading →
Reading time: 7 minutes Gracie Jennah Mead Introduction Macrophages are an important part of the innate immune system. Within the innate immune system, which comprises more indiscriminate strategies that protect us from pathogens in general, macrophages engulf and break down pathogens. Macrophages are a diverse cell as they can regulate tissue development and tissue repair... Continue Reading →
Reading time: 4 minutes Shan Grewal Cancer has long been a formidable adversary in the world of medicine, but recent advancements in the field of immunotherapy have offered new hope in the battle against this complex disease. Immunotherapy is a revolutionary approach that harnesses the body's immune system to target and eliminate cancer cells. One... Continue Reading →
Reading time: 6 minutes Gracie Jennah Mead Introduction Exhausted T cells (Tex) were first discovered during chronic viral infections whereby the CD8 T cells (which are a type of immune cell that initiates killing of virally infected cells and cancerous cells) persist but can no longer clear the pathogen, this was first evident in HIV... Continue Reading →
Reading time: 8 minutes Alex DeWalle At the core of translational oncology lies a fundamental problem: how do we kill tumor cells without harming healthy tissue? Novel therapies must directly target tumor cells to achieve this goal in a way that traditional chemotherapies cannot. CAR T-cell therapy (CAR T) is one of the most promising... Continue Reading →
Reading time: 4 minutes Mallory Kane The immune system is the first line of defense in detecting and destroying cancer cells. Several mechanisms are in place to prevent and slow cancer growth. However, cancerous cells often can avoid destruction by the immune system. These cells may contain genetic mutations that make them invisible to immune... Continue Reading →
Reading time: 5 minutes Colette Bilynsky New treatment strategies are almost constantly being tested in pre-clinical research and clinical trials, with many of them outlined in various OncoBites articles. This is incredibly important work as groundbreaking treatment strategies like CAR-T therapy have the capacity to radically improve patient outcomes. CAR-T therapy takes the patient's own... Continue Reading →
Reading time: 5 minutes Hema Saranya Ilamathi Viruses have long been associated with illnesses in humans, like the flu and AIDS, but many people are unaware that some viruses can be used to treat cancer. Oncolytic viruses (OVs) are natural or genetically engineered viruses that selectively target and destroy cancer cells. Using viruses to treat... Continue Reading →
Reading time: 4 minutes Indiwari Gopallawa After years of seminal research work, mRNA technology got its moment as a result of the Covid-19 pandemic. However, mRNA-based cancer vaccines remain a relatively new and untapped class of vaccines that show great potential. The enthusiasm for this novel technology has been increasing due to recently published experimental... Continue Reading →
Reading time: 3 minutes Susan Egbert Pediatric cancer is a broad term that refers to cancers originating in children younger than 18. There are different types of pediatric cancer, but they all fall into one of two categories: solid tumors and leukemia. Solid tumors are cancers arising from cells in the body's tissues. These tumors... Continue Reading →
Reading time: 4 minutes Indiwari Gopallawa Cancer is the second leading cause of death after cardiovascular diseases in the United States and has a major impact on society. Lung cancer is the second most common cancer type and is associated with lower survival rates and higher cancer-related deaths, accounting for 25% of all cancer-related deaths... Continue Reading →
Colette Bilynsky CAR-T cell therapy is widely available in the United States, with 6 FDA-approved formulations, and has been previously discussed on Oncobites. However, a new clinical trial using the CAR (chimeric antigen receptor) technology is underway, but using macrophages instead of T-Cells in the hope of treating more types of cancer. But let’s take... Continue Reading →
Reading time: 4 minutes Hema Saranya Ilamathi Beep! Beep! There goes the metal scanner in the airport. Oops! I realized that I forgot to take out the key chain from my pocket. Similar to the metal detection system, our body has a highly vigilant surveillance system called immune cells that constantly scan for the presence... Continue Reading →
Reading time: 5 minutes Christina Niavi Our human body has amazing defense mechanisms. The organism defense is like the army, with a first line of defense against any kind of threat and, a second defense, more specialized to each threat. Specialized defense soldiers, called CD8 T cells, are equipped with killing machineries to eradicate tumors... Continue Reading →
Reading time: 7 minutes Felicites Rapon Hepatitis C virus (HCV) is the causative agent of hepatitis C, an infectious disease of the liver causing inflammation and necrosis. HCV infection can be either acute (which can be cleared without any medicines) or chronic. The latter can be due to environmental factors such as alcohol usage but... Continue Reading →
Reading time: 5 minutes Deanna MacNeil One goal in cancer therapy is to strike a balance between treatment efficacy and toxicity. While treatments such as surgery, chemotherapy, and radiation are meant to kill cancer cells, healthy tissues can be adversely affected in the process. Common side effects of systemic cancer treatment occur because treatments work... Continue Reading →
Reading time: 4 minutes Kate Secombe You may have read previously on OncoBites about immunotherapies, and the great promise they hold in treating a wide range of cancers. Commonly used immunotherapies include checkpoint inhibitors such as PD-1 or CTLA-4 inhibitors. Here I will be looking at an emerging subset of immunotherapies known as immune agonist... Continue Reading →
Reading time: 5 minutes Mahrukh Fatima Our bodies are quite spectacular and are well-equipped to protect us from most dangers we encounter, both internal and external. The tools our bodies use to protect us against microscopic threats are collectively known as the immune system, and just like tools in a toolbox, the different types of... Continue Reading →
Reading time: 7 minutes Aishat Motolani You have most likely heard of several branded FDA-approved drugs during TV commercials and sighed, “Ah! not again with this rhythmic list of symptoms.” Well, some of those symptoms may have included immune-related adverse events (IRAEs). iRAEs are composed of an array of side effects that are reminiscent of... Continue Reading →
Estimated reading time: 5 minutes Payal Yokota One of the main differences between a rapidly dividing cancer cell and a normal cell is that the cancer cells rely on glycolysis followed by lactic acid fermentation, rather than oxidative phosphorylation. This effect is called the Warburg effect, one we have previously discussed in the context of... Continue Reading →
Reading time: 4 minutes Aileen I Fernandez When a foreign substance such as a cancer cell presents itself in the human body, it is able to communicate with cells of the human immune system. The cancer cell signals the immune system, telling it “Hey! Pump the brakes!”, thus instructing the immune system to not kill... Continue Reading →
Sara Musetti Estimated reading time: 5 minutes It seems talking about the immune system and how it can fight cancer is all the rage these days, especially here at OncoBites. But talking about it can be tricky, especially because most people seldom think about their immune system. It’s a part of your body, but… which... Continue Reading →
Reading time: 3 minutes Natasha Vinod In 2018, the Nobel Prize in Physiology or Medicine was awarded to the inventors of immune checkpoint blockade therapy, a “game-changing” technology that initiated a paradigm shift in cancer management. Checkpoint blockade therapy works by unleashing the immune surveillance against cancer by blocking the “natural brakes” (checkpoints) in the... Continue Reading →
Reading time: 4 minutes Aishwarya Subramanian At Oncobites we've covered the exciting emerging field of immunotherapy to treat cancer, some of which include PROTACs and BiTE molecules . Recently, significant advances have been made when trying to come up with cutting edge ideas for cancer treatment. With the recent changes in the landscape of cancer... Continue Reading →
Reading time: 4 minutes Manisit Das From the early days of OncoBites, we are trying to share with you the reasons we get cancer. Cancer arises when the DNA in our cells is altered due to irreparable mistakes in the cellular machinery or environmental effects. If a mistake happens in the proteins that help repair... Continue Reading →
Reading time: 5 minutes Payal Yokota Can viruses be heroes? It is well-known that some viruses can cause severe infections in the body. However, when modified in the correct way, these small molecular entities can be used as an additional arsenal in the immune tool bag, to kill even bigger and scarier enemies… such as... Continue Reading →
Reading time: 4 minutes Alex S. Woodell In my previous article, we weathered the cytokine storm, a deadly immune response that can occur following chimeric antigen receptor T cell (CAR-T) therapy. Despite this risk, CAR-T therapy is quite effective in treating blood cancers such as acute lymphoblastic leukemia (ALL). Unfortunately, not all patients respond favorably... Continue Reading →
Reading time- 4 minutes Sara Musetti The overwhelming majority of cancer “breakthroughs” that get reported on are expensive, state-of-the-art therapies that rely more and more on deeper and deeper knowledge of tumors. And those are extremely important therapies. However, these shiny discoveries tend to hide an interesting fact: our best cancer treatment is also our... Continue Reading →
OncoBites 